119 related articles for article (PubMed ID: 7556256)
1. Assessment of the safety and efficacy of iobitridol, an iodinated contrast medium (30% iodine), in cranial CT.
Taylor W; Moseley I
Eur J Radiol; 1995 May; 20(1):57-60. PubMed ID: 7556256
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
[TBL] [Abstract][Full Text] [Related]
3. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
Smets A; Shaw D
Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
[TBL] [Abstract][Full Text] [Related]
4. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
Hoogewoud HM; Woessmer B
Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography.
Lefevre T; Funck F; Aliot E; Ethevenot B
Acta Radiol Suppl; 1996; 400():75-80. PubMed ID: 8619358
[TBL] [Abstract][Full Text] [Related]
6. Iobitridol 250 vs iohexol 240 in phlebography of th lower limbs. A double-blind clinical trial.
Chagnaud C; Moulin G; Bartoli JM; Rousseau H; Railhac JJ; Lyonnet D
Acta Radiol Suppl; 1996; 400():89-91. PubMed ID: 8619362
[TBL] [Abstract][Full Text] [Related]
7. Clinical safety and efficacy of iobitridol in urography.
Meiss L; Bakker AJ; Falke TH; Van Waes PF
Acta Radiol Suppl; 1996; 400():68-71. PubMed ID: 8619356
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with iobitridol 250-300 in digital subtraction angiography. Double-blind randomized studies vs. iopromide and iohexol.
Bouard JC; Lyonnet D; Illes JP; Bouard-Monnier C; Rouviere O; Pangaud C
Acta Radiol Suppl; 1996; 400():85-8. PubMed ID: 8619361
[TBL] [Abstract][Full Text] [Related]
9. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of Xenetix, a new iodinated contrast agent, in pediatric angiocardiography.
Rossignol AM; Lusson JR; Chantepie A; Losay J
Acta Radiol Suppl; 1996; 400():81-4. PubMed ID: 8619360
[TBL] [Abstract][Full Text] [Related]
11. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
[TBL] [Abstract][Full Text] [Related]
12. Iobitridol: a review of its use as a contrast medium in diagnostic imaging.
McCormack PL
Clin Drug Investig; 2013 Feb; 33(2):155-66. PubMed ID: 23341290
[TBL] [Abstract][Full Text] [Related]
13. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
Stockx L; Wilms G; Baert AL; Terrier F
Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of iobitridol in patients with non-immediate hypersensitivity reactions to iodinated contrast media.
Gracia-Bara MT; Moreno E; Laffond E; Muñoz-Bellido F; Lázaro M; Macías E; de Arriba S; Campanón V; Sobrino M; Dávila I
Allergy; 2019 Jan; 74(1):195-197. PubMed ID: 30225896
[No Abstract] [Full Text] [Related]
15. CT pulmonary angiography with a macromolecular contrast medium: a comparative study versus iobitridol in rabbits.
Wiart M; Corot C; Berthezene Y; Violas X; Canet E
Invest Radiol; 2001 Sep; 36(9):547-53. PubMed ID: 11547043
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
[TBL] [Abstract][Full Text] [Related]
17. Influence of a new monomeric nonionic radiographic contrast medium (iobitridol-350 versus NaCl) on cutaneous microcirculation: single-center, prospective, randomized, double-blind phase IV study in parallel group design.
Bach R; Gerk U; Mrowietz C; Jung F
Microvasc Res; 2000 Nov; 60(3):193-200. PubMed ID: 11078635
[TBL] [Abstract][Full Text] [Related]
18. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol.
Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C
Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients.
Maurer M; Heine O; Wolf M; Freyhardt P; Schnapauff D; Hamm B
Eur J Radiol; 2011 Nov; 80(2):357-62. PubMed ID: 20395094
[TBL] [Abstract][Full Text] [Related]
20. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
Schmiedel E
Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
